ASD
Clinical trials for ASD explained in plain language.
Never miss a new study
Get alerted when new ASD trials appear
Sign up with your email to follow new studies for ASD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could stem cells and glutathione ease autism symptoms? new trial seeks answers
Disease control Recruiting nowThis 24-month study tests whether adding umbilical cord stem cells (AdiaVita) to glutathione therapy helps improve autism symptoms in children ages 3-12. About 100 kids will be randomly assigned to get either glutathione alone or glutathione plus stem cell infusions. Parents and …
Matched conditions: ASD
Phase: PHASE1, PHASE2 • Sponsor: Adia Med of Winter Park LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New telehealth program aims to help autistic kids with bowel accidents
Disease control Recruiting nowThis study tests whether a caregiver-led telehealth program can help autistic children ages 5 to 12 who still have bowel accidents after completing treatment for bedwetting. About 150 children will take part. The program teaches caregivers strategies to manage encopresis, with th…
Matched conditions: ASD
Phase: PHASE4 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cord blood stem cells trialed for autism – but Don't get your hopes up yet
Disease control Recruiting nowThis study tests whether a combination of umbilical cord stem cells and glutathione can safely improve autism symptoms in 100 people aged 3 and older. Participants receive either the stem cell product plus glutathione, or a placebo plus glutathione, with the option to switch grou…
Matched conditions: ASD
Phase: PHASE1 • Sponsor: Greater Atlanta Integrative Pediatrics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Old drug, new hope: spironolactone may help kids with rare Autism-Linked gene mutations
Disease control Recruiting nowThis study tests whether spironolactone, a common diuretic, can improve learning and behavior in children aged 3–10 with NCOR gene mutations, which are linked to autism spectrum disorder. Only 2 children will be enrolled, and researchers will measure changes in intelligence and a…
Matched conditions: ASD
Phase: PHASE2, PHASE3 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Where's best for autism therapy? home or center? new study aims to find out.
Symptom relief Recruiting nowThis study tests whether a 16-week behavioral therapy called Pivotal Response Treatment (PRT) works better when done at a center or at home for young children with autism who have language delays. Researchers will compare both groups to children receiving usual care. The goal is …
Matched conditions: ASD
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a modified MDMA ease autism symptoms? small trial begins
Symptom relief Recruiting nowThis study tests a drug called DT402 (a form of MDMA) in 20 adults with autism spectrum disorder. The goal is to see if it can reduce the severity of social and communication problems. Participants will take the drug and report their experiences using simple rating scales. It is …
Matched conditions: ASD
Phase: PHASE2 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Fish oil for autism: new study tests if Omega-3s calm behavior
Symptom relief Recruiting nowThis study tests whether omega-3 supplements can reduce behavioral problems in children and teens with autism spectrum disorder (ASD). Over 12 weeks, 50 participants aged 6-17 will take omega-3 or a placebo. Researchers will measure changes in behavior, attention, and blood marke…
Matched conditions: ASD
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Autism clues found in blood and brain scans of young children
Knowledge-focused Recruiting nowThis study compares children with autism spectrum disorder (ASD) to typically developing children, aged 3 to 5 years. Researchers measure a substance called N-CAD in the blood and use a non-invasive brain imaging technique (fNIRS) to look at brain activity during rest and social …
Matched conditions: ASD
Sponsor: Chen Li • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC